Down-modulation of the antigen receptor by a superantigen for human B cells

被引:14
|
作者
Viau, M
Cholley, B
Björck, L
Zouali, M
机构
[1] INSERM, U430, F-75006 Paris, France
[2] Lund Univ, Dept Cell & Mol Biol, S-22100 Lund, Sweden
关键词
B cell receptor; receptor internalization; protein L;
D O I
10.1016/j.imlet.2003.10.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B cell superantigens (SAgs) have been implicated in human diseases by demonstrating non-clonotypic expansion of B cells bearing certain immunoglobulin variable region genes. One possibility is that, during infection with microorganisms secreting SAgs, these potent molecules might modulate BcR expression. To test this hypothesis, we investigated the potential effects of a SAg, protein L from Peptostreptococcus magnus, on antigen B cell receptor (BcR) surface expression in vitro. Using fluorescence microscopy, we found that this SAg induced down-regulation of BcR expression. This effect was time-, dose-, and temperature-dependent, and shedding of cell surface IgM molecules into the culture supernatant was not detected. These data demonstrate that SAg-mediated down-regulation of the BcR expression occurs primarily as a result of BcR internalization. In addition, two specific inhibitors of protein tyrosine kinases were found to retard the BcR modulation on the cell surface and inhibit SAg-induced receptor internalization, showing that tyrosine phosphorylation is required for subsequent internalization of mIg-ligand complexes. The down-modulation of BcR expression may have pathological consequences in patients infected with microorganisms secreting SAgs. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 50 条
  • [1] Down-modulation of CD2 delays deletion of superantigen-responsive T cells
    Fortner, KA
    Russell, JQ
    Budd, RC
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (01) : 70 - 79
  • [2] DESENSITIZATION OF ISLET CELLS TO BOMBESIN INVOLVES BOTH RECEPTOR DOWN-MODULATION AND INHIBITION OF RECEPTOR FUNCTION
    SWOPE, SL
    SCHONBRUNN, A
    MOLECULAR PHARMACOLOGY, 1990, 37 (05) : 758 - 766
  • [3] Tucaresol down-modulation of MUC1-stimulated human mononuclear cells
    Wright, Stephen E.
    Rewers-Felkins, Kathleen A.
    Chowdhury, Nazrul I.
    Ahmed, Jewel
    Srivastava, Sanjay K.
    Lockwood-Cooke, Pamela R.
    IMMUNOLOGICAL INVESTIGATIONS, 2014, 43 (02) : 160 - 169
  • [4] Induction of "antigen silencing" in melanomas by oncostatin M: Down-modulation of melanocyte antigen expression
    Durda, PJ
    Dunn, IS
    Rose, LB
    Butera, D
    Benson, EM
    Pandolfi, F
    Kurnick, JT
    MOLECULAR CANCER RESEARCH, 2003, 1 (06) : 411 - 419
  • [5] Down-modulation of chemokine receptor cartilage expression in inflammatory arthritis
    Silvestri, T
    Meliconi, R
    Pulsatelli, L
    Dolzani, P
    Zizzi, F
    Frizziero, L
    Borzì, RM
    Facchini, A
    RHEUMATOLOGY, 2003, 42 (01) : 14 - 18
  • [6] DOWN-MODULATION OF EGF RECEPTORS IN CELLS TRANSFORMED BY THE SRC ONCOGENE
    WASILENKO, WJ
    SHAWVER, LK
    WEBER, MJ
    JOURNAL OF CELLULAR PHYSIOLOGY, 1987, 131 (03) : 450 - 457
  • [7] DOWN-MODULATION OF NEUTROPHIL PRODUCTION BY ERYTHROPOIETIN IN HUMAN HEMATOPOIETIC CLONES
    CHRISTENSEN, RD
    KOENIG, JM
    VISKOCHIL, DH
    ROTHSTEIN, G
    BLOOD, 1989, 74 (02) : 817 - 822
  • [8] The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion
    Wilson, MT
    Johansson, C
    Olivares-Villagómez, D
    Singh, AK
    Stanic, AK
    Wang, CR
    Joyce, S
    Wick, MJ
    Van Kaer, L
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) : 10913 - 10918
  • [9] Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation
    Gandillet, A.
    Park, S.
    Lassailly, F.
    Griessinger, E.
    Vargaftig, J.
    Filby, A.
    Lister, T. A.
    Bonnet, D.
    LEUKEMIA, 2011, 25 (05) : 770 - 780
  • [10] Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation
    A Gandillet
    S Park
    F Lassailly
    E Griessinger
    J Vargaftig
    A Filby
    T A Lister
    D Bonnet
    Leukemia, 2011, 25 : 770 - 780